{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:20:54Z","timestamp":1788380454071,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473436"],"award-info":[{"award-number":["82473436"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403348"],"award-info":[{"award-number":["82403348"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103000"],"award-info":[{"award-number":["82103000"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303033"],"award-info":[{"award-number":["82303033"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202911"],"award-info":[{"award-number":["82202911"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012149","name":"National Key Scientific Instrument and Equipment Development Projects of China","doi-asserted-by":"publisher","award":["81927807"],"award-info":[{"award-number":["81927807"]}],"id":[{"id":"10.13039\/501100012149","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M751032"],"award-info":[{"award-number":["2024M751032"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010580","name":"Department of Science and Technology, Hubei Provincial People's Government","doi-asserted-by":"publisher","award":["2024AFB640"],"award-info":[{"award-number":["2024AFB640"]}],"id":[{"id":"10.13039\/501100010580","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010580","name":"Department of Science and Technology, Hubei Provincial People's Government","doi-asserted-by":"publisher","award":["2023AFB416"],"award-info":[{"award-number":["2023AFB416"]}],"id":[{"id":"10.13039\/501100010580","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jare.2025.08.007","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T15:52:45Z","timestamp":1754668365000},"page":"677-694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Epigenetically silenced KAT2B suppresses de novo lipogenesis through destroying HDAC5\/LSD1 complex assembly in renal cell carcinoma"],"prefix":"10.1016","volume":"83","author":[{"given":"Qi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daojia","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuenan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0218-3288","authenticated-orcid":false,"given":"Xiaoping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jare.2025.08.007_b0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.jare.2025.08.007_b0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41581-023-00800-2","article-title":"Metabolic alterations in hereditary and sporadic renal cell carcinoma","volume":"20","author":"Coffey","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jare.2025.08.007_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(24)00917-6","article-title":"Renal cell carcinoma","author":"Young","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jare.2025.08.007_b0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","article-title":"Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer","volume":"31","author":"Snaebjornsson","year":"2020","journal-title":"Cell Metab"},{"issue":"11","key":"10.1016\/j.jare.2025.08.007_b0025","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","article-title":"The role of lipids in cancer progression and metastasis","volume":"34","author":"Martin-Perez","year":"2022","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.jare.2025.08.007_b0030","article-title":"Metabolic reprogramming in renal cancer: events of a metabolic disease","volume":"1876","author":"Chakraborty","year":"2021","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10.1016\/j.jare.2025.08.007_b0035","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"16","key":"10.1016\/j.jare.2025.08.007_b0040","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1016\/j.molcel.2022.06.003","article-title":"An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma","volume":"82","author":"Zhou","year":"2022","journal-title":"Mol Cell"},{"issue":"7","key":"10.1016\/j.jare.2025.08.007_b0045","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41419-024-06896-z","article-title":"N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1\/IQGAP2\/AKT signaling pathway","volume":"15","author":"Tan","year":"2024","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.jare.2025.08.007_b0050","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/cac2.12413","article-title":"N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2\/YAP axis-regulated Hippo pathway","volume":"43","author":"Miao","year":"2023","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.jare.2025.08.007_b0055","article-title":"ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to function as a lactyltransferase for histone lactylation and tumor immune evasion","author":"Zhu","year":"2024","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.jare.2025.08.007_b0060","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.canlet.2016.02.053","article-title":"PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1","volume":"375","author":"Li","year":"2016","journal-title":"Cancer Lett"},{"issue":"31","key":"10.1016\/j.jare.2025.08.007_b0065","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1038\/onc.2009.137","article-title":"Characterization of tumor suppressive function of P300\/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma","volume":"28","author":"Zhu","year":"2009","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.jare.2025.08.007_b0070","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41419-018-0470-8","article-title":"Down-regulation of a pro-apoptotic pathway regulated by PCAF\/ADA3 in early stage gastric cancer","volume":"9","author":"Brasacchio","year":"2018","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.jare.2025.08.007_b0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13046-024-03036-5","article-title":"The histone lysine acetyltransferase KAT2B inhibits cholangiocarcinoma growth: evidence for interaction with SP1 to regulate NF2-YAP signaling","volume":"43","author":"Ma","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.jare.2025.08.007_b0080","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1158\/0008-5472.CAN-20-2828","article-title":"HDAC5 loss impairs RB repression of pro-oncogenic genes and confers CDK4\/6 inhibitor resistance in cancer","volume":"81","author":"Zhou","year":"2021","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.jare.2025.08.007_b0085","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.7150\/thno.69444","article-title":"HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer","volume":"12","author":"Zhou","year":"2022","journal-title":"Theranostics"},{"issue":"24","key":"10.1016\/j.jare.2025.08.007_b0090","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1158\/0008-5472.CAN-21-4362","article-title":"HDAC5 loss enhances phospholipid-derived arachidonic acid generation and confers sensitivity to cPLA2 inhibition in pancreatic cancer","volume":"82","author":"Pan","year":"2022","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.jare.2025.08.007_b0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41392-021-00714-0","article-title":"Glucose-sensitive acetylation of Seryl tRNA synthetase regulates lipid synthesis in breast cancer","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"6808","key":"10.1016\/j.jare.2025.08.007_b0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/35040593","article-title":"Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation","volume":"408","author":"McKinsey","year":"2000","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jare.2025.08.007_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114054","article-title":"14-3-3 binding motif phosphorylation disrupts Hdac4-organized condensates to stimulate cardiac reprogramming","volume":"43","author":"Liu","year":"2024","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.jare.2025.08.007_b0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/onc.2016.186","article-title":"Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression","volume":"36","author":"Cao","year":"2017","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.jare.2025.08.007_b0115","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ccell.2019.09.005","article-title":"Re-programing chromatin with a bifunctional LSD1\/HDAC inhibitor induces therapeutic differentiation in DIPG","volume":"36","author":"Anastas","year":"2019","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.jare.2025.08.007_b0120","doi-asserted-by":"crossref","first-page":"e2879","DOI":"10.1038\/cddis.2017.239","article-title":"Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells","volume":"8","author":"Haydn","year":"2017","journal-title":"Cell Death Dis"},{"issue":"7","key":"10.1016\/j.jare.2025.08.007_b0125","doi-asserted-by":"crossref","first-page":"e970","DOI":"10.1002\/ctm2.970","article-title":"Patient-derived renal cell carcinoma organoids for personalized cancer therapy","volume":"12","author":"Li","year":"2022","journal-title":"Clin Transl Med"},{"issue":"1","key":"10.1016\/j.jare.2025.08.007_b0130","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12967-021-03087-8","article-title":"CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt\/\u03b2-catenin signaling pathway","volume":"19","author":"Wang","year":"2021","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/j.jare.2025.08.007_b0135","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1167\/iovs.18-25802","article-title":"Optic nerve lipidomics reveal impaired glucosylsphingosine lipids pathway in glaucoma","volume":"60","author":"Chauhan","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jare.2025.08.007_b0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12859-017-1579-y","article-title":"metaX: a flexible and comprehensive software for processing metabolomics data","volume":"18","author":"Wen","year":"2017","journal-title":"BMC Bioinf"},{"issue":"2","key":"10.1016\/j.jare.2025.08.007_b0145","doi-asserted-by":"crossref","first-page":"841","DOI":"10.7150\/thno.49384","article-title":"ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3","volume":"11","author":"Zhou","year":"2021","journal-title":"Theranostics"},{"issue":"W1","key":"10.1016\/j.jare.2025.08.007_b0150","doi-asserted-by":"crossref","first-page":"W234","DOI":"10.1093\/nar\/gkz240","article-title":"NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis","volume":"47","author":"Zhou","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.jare.2025.08.007_b0155","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.ajpath.2017.07.022","article-title":"Oncogenic determination of a broad spectrum of phenotypes of hepatocyte-derived mouse liver tumors","volume":"187","author":"Yamamoto","year":"2017","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.jare.2025.08.007_b0160","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/hep4.1327","article-title":"Emergence of the dedifferentiated phenotype in hepatocyte-derived tumors in mice: roles of oncogene-induced epigenetic alterations","volume":"3","author":"Watanabe","year":"2019","journal-title":"Hepatol Commun"},{"issue":"3","key":"10.1016\/j.jare.2025.08.007_b0165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","article-title":"Dynamics and functions of lipid droplets","volume":"20","author":"Olzmann","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.jare.2025.08.007_b0170","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","article-title":"Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics","volume":"16","author":"Jin","year":"2023","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jare.2025.08.007_b0175","doi-asserted-by":"crossref","first-page":"13227","DOI":"10.1038\/ncomms13227","article-title":"KAT2A\/KAT2B-targeted acetylome reveals a role for PLK4 acetylation in preventing centrosome amplification","volume":"7","author":"Fournier","year":"2016","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.jare.2025.08.007_b0180","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.247874","article-title":"Cargo transport through the nuclear pore complex at a glance","volume":"134","author":"Paci","year":"2021","journal-title":"J Cell Sci"},{"issue":"6","key":"10.1016\/j.jare.2025.08.007_b0185","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1172\/JCI128073","article-title":"Hepatic Slug epigenetically promotes liver lipogenesis, fatty liver disease, and type 2 diabetes","volume":"130","author":"Liu","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jare.2025.08.007_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.154011","article-title":"LSD1 mediates microbial metabolite butyrate-induced thermogenesis in brown and white adipose tissue","volume":"102","author":"Wang","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.jare.2025.08.007_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174459","article-title":"Chaetocin: a review of its anticancer potentials and mechanisms","volume":"910","author":"Jiang","year":"2021","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jare.2025.08.007_b0200","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.jare.2025.08.007_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092071","article-title":"The role of epigenetics in the progression of clear cell renal cell carcinoma and the basis for future epigenetic treatments","volume":"13","author":"Angulo","year":"2021","journal-title":"Cancers"},{"issue":"25","key":"10.1016\/j.jare.2025.08.007_b0210","doi-asserted-by":"crossref","first-page":"11444","DOI":"10.7150\/thno.48469","article-title":"Restoring the epigenetically silenced PCK2 suppresses renal cell carcinoma progression and increases sensitivity to sunitinib by promoting endoplasmic reticulum stress","volume":"10","author":"Xiong","year":"2020","journal-title":"Theranostics"},{"issue":"13","key":"10.1016\/j.jare.2025.08.007_b0215","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1158\/1078-0432.CCR-22-2807","article-title":"Ahase II investigation of TVB-2640 (denifanstat) with bevacizumab in patients with first relapse high-grade astrocytoma","volume":"29","author":"Kelly","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.jare.2025.08.007_b0220","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","article-title":"Lipid metabolism in cancer: new perspectives and emerging mechanisms","volume":"56","author":"Broadfield","year":"2021","journal-title":"Dev Cell"},{"issue":"12","key":"10.1016\/j.jare.2025.08.007_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111396","article-title":"Targeting the USP7\/RRM2 axis drives senescence and sensitizes melanoma cells to HDAC\/LSD1 inhibitors","volume":"40","author":"Granieri","year":"2022","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.jare.2025.08.007_b0230","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41467-017-02242-4","article-title":"Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors","volume":"9","author":"Kalin","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jare.2025.08.007_b0235","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ccell.2022.12.001","article-title":"Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness","volume":"41","author":"Li","year":"2023","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.jare.2025.08.007_b0240","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41585-022-00592-3","article-title":"Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma","volume":"19","author":"Ingels","year":"2022","journal-title":"Nat Rev Urol"},{"issue":"6","key":"10.1016\/j.jare.2025.08.007_b0245","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/ans.18920","article-title":"Nurse-led renal cell carcinoma clinic: a single center review","volume":"94","author":"Thia","year":"2024","journal-title":"ANZ J Surg"},{"issue":"6","key":"10.1016\/j.jare.2025.08.007_b0250","first-page":"507","article-title":"Treatment of renal cell carcinoma: current status and future directions","volume":"67","author":"Barata","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.jare.2025.08.007_b0255","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/CU9.0000000000000089","article-title":"The value of sestamibi single-photon emission computed tomography\/computed tomography in differentiating and staging renal cell carcinomas: a systematic review","volume":"16","author":"Deb","year":"2022","journal-title":"Curr Urol"},{"issue":"5","key":"10.1016\/j.jare.2025.08.007_b0260","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ccell.2021.02.015","article-title":"Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma","volume":"39","author":"Bi","year":"2021","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.jare.2025.08.007_b0265","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13046-021-01961-3","article-title":"Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma","volume":"40","author":"Sharma","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.jare.2025.08.007_b0270","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10555-021-09996-w","article-title":"Lipid metabolism reprogramming in renal cell carcinoma","volume":"41","author":"Heravi","year":"2022","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.jare.2025.08.007_b0275","article-title":"MIER2\/PGC1A elicits sunitinib resistance via lipid metabolism in renal cell carcinoma","author":"Wei","year":"2024","journal-title":"J Adv Res"},{"issue":"12","key":"10.1016\/j.jare.2025.08.007_b0280","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1158\/0008-5472.CAN-22-3105","article-title":"ZDHHC2-mediated AGK palmitoylation activates AKT-mTOR signaling to reduce sunitinib sensitivity in renal cell carcinoma","volume":"83","author":"Sun","year":"2023","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.jare.2025.08.007_b0285","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12607","article-title":"Melatonin\/PGC1A\/UCP1 promotes tumor slimming and represses tumor progression by initiating autophagy and lipid browning","volume":"67","author":"Xiao","year":"2019","journal-title":"J Pineal Res"},{"issue":"10","key":"10.1016\/j.jare.2025.08.007_b0290","article-title":"Tumor cell \u201cslimming\u201d regulates tumor progression through PLCL1\/UCP1-mediated lipid browning","volume":"6","author":"Xiong","year":"2019","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.jare.2025.08.007_b0295","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41392-022-01099-4","article-title":"Discovery of a mammalian FASN inhibitor against xenografts of non-small cell lung cancer and melanoma","volume":"7","author":"Cao","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"10.1016\/j.jare.2025.08.007_b0300","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/j.gastro.2021.07.025","article-title":"TVB-2640 (FASN Inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled phase 2a trial","volume":"161","author":"Loomba","year":"2021","journal-title":"Gastroenterology"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209012322500596X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209012322500596X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:01:04Z","timestamp":1778835664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S209012322500596X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":60,"alternative-id":["S209012322500596X"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.08.007","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetically silenced KAT2B suppresses de novo lipogenesis through destroying HDAC5\/LSD1 complex assembly in renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}